Markus Knuf

6.5k citations
157 papers · 5.1k · 2 hit papers · h-index 37

Impact in

Papers in

    • Bacterial Infections and Vaccines 42
    • Influenza Virus Research Studies 18
    • Pneumonia and Respiratory Infections 12
    • Respiratory viral infections research 8
    • Herpesvirus Infections and Treatments 7

Markus Knuf

148 papers receiving 4.7k citations

Markus Knuf's Hit Papers

180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial 2025 · 26 citations
260+1+2Years since publication50100150200250

Peers

Markus Knuf
Comparison fields: 5 of 122
  • Microbiology 1.2k
  • Applied Microbiology and Biotechnology 282
  • Epidemiology 2k
  • Endocrinology 178
  • Health 285
Replace Henry H. Bernstein with:
Henry H. Bernstein United States
Nicole Le Saux Canada
Stephan Michael Marcy United States
David W. Scheifele Canada
Richard F. Jacobs United States
David P. Greenberg United States
Kathleen H. Harriman United States
Åke Örtqvist Sweden
Urs Beat Schaad Switzerland
Javier Díez‐Domingo Spain
Markus Knuf relative to Henry H. Bernstein United States Henry H. Bernstein's profile →
Citations per field
00.5×2×3×3.9×
Henry H. Bernstein · 1×
Citations per year

Countries citing papers authored by Markus Knuf

Since Specialization
Citations

This map shows the geographic impact of Markus Knuf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Knuf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Knuf more than expected).

Fields of papers citing papers by Markus Knuf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Knuf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Knuf. The network helps show where Markus Knuf may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Knuf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Knuf Line = papers co-authored together Markus Knuf links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2011299
2 2019283
3 2011268
4
Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
Hit paper breakdown →
2023257
5 2009202
6 2013144
7 2019143
8 2007121
9 2018115
10 2009107
11 200694
12 201292
13 199687
14 201186
15 202082
16 200979
17 200977
18 200971
19 200970
20 199669

About Markus Knuf

Markus Knuf is a scholar working on Microbiology, Epidemiology, Immunology, Endocrinology and Physiology, having authored 157 papers that have together received 5.1k indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (42 papers), Influenza Virus Research Studies (18 papers), Pneumonia and Respiratory Infections (12 papers), Tuberous Sclerosis Complex Research (11 papers), Respiratory viral infections research (8 papers), Retinopathy of Prematurity Studies (8 papers), Vaccine Coverage and Hesitancy (7 papers) and Herpesvirus Infections and Treatments (7 papers). The work is most often cited by research in Microbiology (1.2k citations), Applied Microbiology and Biotechnology (282 citations), Epidemiology (2k citations), Endocrinology (178 citations) and Health (285 citations). Markus Knuf has collaborated with scholars based in Germany, Belgium and United States. Frequent co-authors include Fred Zepp, Ralf L. Clemens, Heinz‐Josef Schmitt, B. Ruf, Peter Wutzler, Pirmin Habermehl, Theodore F. Tsai, Timo Vesikari, Lode Schuerman and Dorothee Kieninger‐Baum. Their work appears in journals such as Vaccine, The Pediatric Infectious Disease Journal, European Journal of Pediatrics, Human Vaccines & Immunotherapeutics and The Journal of Pediatrics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact